Wealthsource Partners LLC acquired a new position in shares of Mylan NV (NASDAQ:MYL) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 8,418 shares of the company’s stock, valued at approximately $231,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC raised its position in Mylan by 1.9% in the 2nd quarter. FMR LLC now owns 9,171,840 shares of the company’s stock valued at $331,470,000 after purchasing an additional 168,347 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Mylan by 32.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 9,408,218 shares of the company’s stock valued at $340,012,000 after acquiring an additional 2,284,545 shares during the last quarter. Andra AP fonden increased its holdings in shares of Mylan by 11.5% in the 3rd quarter. Andra AP fonden now owns 140,200 shares of the company’s stock valued at $5,131,000 after acquiring an additional 14,500 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Mylan by 14.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 150,874 shares of the company’s stock valued at $5,522,000 after acquiring an additional 19,019 shares during the last quarter. Finally, BB&T Corp purchased a new position in shares of Mylan in the 3rd quarter valued at about $202,000. Institutional investors and hedge funds own 83.16% of the company’s stock.
A number of research firms have recently commented on MYL. Morgan Stanley increased their price objective on Mylan from $36.00 to $39.00 and gave the company a “hold” rating in a report on Tuesday, November 6th. Cowen set a $31.00 price objective on Mylan and gave the company a “hold” rating in a report on Tuesday, November 6th. Cantor Fitzgerald reiterated a “hold” rating and issued a $41.00 price objective on shares of Mylan in a report on Tuesday, November 20th. Argus upgraded Mylan from a “hold” rating to a “buy” rating and set a $42.00 price objective on the stock in a report on Thursday, November 15th. Finally, Mizuho reiterated a “neutral” rating on shares of Mylan in a report on Thursday, January 31st. Two analysts have rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. Mylan has a consensus rating of “Hold” and a consensus price target of $42.86.
COPYRIGHT VIOLATION NOTICE: “Wealthsource Partners LLC Takes $231,000 Position in Mylan NV (MYL)” was first posted by BBNS and is the property of of BBNS. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://baseballnewssource.com/2019/02/19/wealthsource-partners-llc-takes-231000-position-in-mylan-nv-myl/3228316.html.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Read More: What is the price-sales ratio?
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.